This study, led by Michael Zumstein and Natalie Wichmann from EDGE, investigated the fate of ten antimicrobial peptides in wastewater, with a focus on early treatment stages and extracellular processes therein. Using high-resolution mass spectrometry, the researchers found varying biotransformation kinetics for the different tested antimicrobial peptides and highly conserved peptidase specificities across different wastewater treatment samples. The insights can be used in the selection and design of novel peptide-based antibiotics and pharmaceuticals that are rapidly degradable in wastewater to reduce the release of such chemicals into the environment.